(Livneh et al., 2017 (link)). Mice
were anesthetized with isoflurane in 100% O2 (induction, 3%;
maintenance, 1–2%), and placed into a stereotaxic apparatus (Kopf
model 963 or Stoelting). After exposing the skull via a small incision,
a small hole was drilled for injection. A pulled-glass pipette with
20–40 μm tip diameter was inserted into the brain, and
virus was injected using an air pressure system (Picospritzer). A
micromanipulator (Grass Technologies, model S48 stimulator) was used to
deliver the injection at 25 nl/min and the pipette was withdrawn 5 min
after injection. For postoperative care, mice were injected
intraperitoneally with meloxicam (0.5 mg/kg). Mice were 8–14
weeks old at the time of injection, except for CRACM experiments, for
which mice were 7–10 weeks old.
We used the following volumes of virus and injection
coordinates: InsCtx (100–200 nl, Bregma: AP: 0.0, 0.4 mm, DV:
−4.1, −4.3 mm, ML: ~4.0 mm), SFO (50 nl per DV
depth, Bregma: AP: −0.65 mm, DV:
−2.3/−2.45/−2.6 mm, ML: 0 mm), MnPO (50 nl, Bregma:
AP: +0.5 mm, DV: −5.2 mm, ML: 0 mm), ARC (200 nl, Bregma: AP:
−1.45 mm, DV: −5.85 mm, ML: ±0.25 mm), PVT
(25–50 nl, Bregma: AP: −1.0, −1.3 mm, DV:
−3.0, −3.0 mm, ML: 0.0, 0.0 mm), BLA (100 nl, Bregma: AP:
−1.6 mm, DV: −4.5, −4.76 mm, ML: ±3.3
mm).